Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiron

Showing results (871-880 of 892) with videos related to

Pageof 90
Sort By:
Clinical and Translational Science|May 10, 2025
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic FibrosisNgoc Hoa Truong, Sihem Benaboud, Naïm Bouazza, et al.
Orphanet Journal of Rare Diseases|June 19, 2012
A national internet-linked based database for pediatric interstitial lung diseases: the French networkNadia Nathan, Rola Abou Taam, Ralph Epaud, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 8, 2023
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis childrenAnnalisa Orenti, Iwona Pranke, Caroline Faucon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 10, 2014
Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective studyAnne Munck, Ahmed Kheniche, Corinne Alberti, et al.
The European Respiratory Journal|February 16, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del <i>CFTR</i> variantPierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, et al.
Nature Cancer|February 5, 2022
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulationLan Wu, Edward Seung, Ling Xu, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn's DiseaseJia Li, Alan J Simmons, Sophie Chiron, et al.
Cell|April 9, 2016
A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityLoredana Vecchione, Valentina Gambino, Jonne Raaijmakers, et al.
Orphanet Journal of Rare Diseases|February 18, 2014
The c.429_452 duplication of the ARX gene: a unique developmental-model of limb kinetic apraxiaAurore Curie, Tatjana Nazir, Amandine Brun, et al.
Nature Communications|August 21, 2024
Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn's diseaseJia Li, Alan J Simmons, Caroline V Hawkins, et al.
Pageof 90

Showing results (871-880 of 892) with videos related to

Sort By:
Pageof 90
Clinical and Translational Science|May 10, 2025
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic FibrosisNgoc Hoa Truong, Sihem Benaboud, Naïm Bouazza, et al.
Orphanet Journal of Rare Diseases|June 19, 2012
A national internet-linked based database for pediatric interstitial lung diseases: the French networkNadia Nathan, Rola Abou Taam, Ralph Epaud, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 8, 2023
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis childrenAnnalisa Orenti, Iwona Pranke, Caroline Faucon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 10, 2014
Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective studyAnne Munck, Ahmed Kheniche, Corinne Alberti, et al.
The European Respiratory Journal|February 16, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del <i>CFTR</i> variantPierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, et al.
Nature Cancer|February 5, 2022
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulationLan Wu, Edward Seung, Ling Xu, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn's DiseaseJia Li, Alan J Simmons, Sophie Chiron, et al.
Cell|April 9, 2016
A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityLoredana Vecchione, Valentina Gambino, Jonne Raaijmakers, et al.
Orphanet Journal of Rare Diseases|February 18, 2014
The c.429_452 duplication of the ARX gene: a unique developmental-model of limb kinetic apraxiaAurore Curie, Tatjana Nazir, Amandine Brun, et al.
Nature Communications|August 21, 2024
Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn's diseaseJia Li, Alan J Simmons, Caroline V Hawkins, et al.
Pageof 90